STERIS plc (STE)
What changed in recent filings
- Institutions — 1 new · 1 added · 2 reduced13F · as of end of 2026 Q2
- Risk factors — 1 added · 4 removed · new: Our investments in our business and product…10-K Mar 31, 2025 → Mar 31, 2026 · filed 4 months ago
What changed in recent SEC filings — factual, not a buy/sell recommendation.
STERIS plc recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Aug 5, 2026Revenue +7.3% YoYReleased after the close: Aug 5 close → Aug 6 close, the stock moved -0.4% · over the same window, market -0.2% · sector -0.1%
- 26Q1Released May 11, 2026Revenue +7.3% YoY · EPS $2.24Released after the close: May 11 close → May 12 close, the stock moved +4.5% · over the same window, market -0.2% · sector +2.1%
- 25Q4Released Feb 4, 2026Revenue +9.2% YoY · EPS $1.96Released after the close: Feb 4 close → Feb 5 close, the stock moved -7.7% · over the same window, market -1.2% · sector -0.4%
- 25Q3Released Nov 5, 2025Revenue +9.9% YoY · EPS $1.94Released after the close: Nov 5 close → Nov 6 close, the stock moved +6.9% · over the same window, market -1.1% · sector +0.0%
The next earnings release is estimated around Nov 4, 2026 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).
Institutions holding STERIS plc
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 1 → 2026 Q2: 5 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold STERIS plc
Institutions we track that reported holding this stock in their most recent 13F.
- Bridgewater Associates0.01% of portfolio · since 2020 Q3
- Generation Investment Management4.67% of portfolio · since 2020 Q3
- National Pension Service (Korea)under 0.01% of portfolio · since 2024 Q1
- Tudor Investment Corp0.03% of portfolio · since 2025 Q2
- BlackstoneNew this quarterunder 0.01% of portfolio · since 2026 Q2
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Q2 2026 13F recap — stocks several institutions bought and sold together →Company overview
STERIS plc is a healthcare and life sciences company that provides infection prevention, contamination control, and procedural products and services. The company offers a broad portfolio that includes sterilizers, surgical tables, endoscopy accessories, cleaning chemistries, instrument and scope repair, laboratory testing, and outsourced reprocessing services. Its operations support hospitals, ambulatory surgery centers, pharmaceutical and medical device manufacturers, and research laboratories. STERIS plc also serves biopharmaceutical and life sciences customers with contamination-control equipment, sterilization technologies, and related maintenance services. Through its mix of consumables, capital equipment, and recurring service offerings, the company plays an important role in helping healthcare and production environments maintain sterile conditions and support patient care across global markets.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
STERIS plc is classified under the Biotech & Health sector. See peers below.
STERIS plc key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
STERIS plc vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding STERIS plc
Per SEC N-PORT · 2026-06-30 · by weight · factual
STE on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
STE FAQ
What is STERIS plc (STE)?
STERIS plc is a healthcare and life sciences company that provides infection prevention, contamination control, and procedural products and services. The company offers a broad portfolio that includes sterilizers, surgical tables, endoscopy accessories, cleaning chemistries, instrument and scope repair, laboratory testing, and outsourced reprocessing services. Its operations support hospitals, ambulatory surgery centers, pharmaceutical and medical device manufacturers, and research laboratories. STERIS plc also serves biopharmaceutical and life sciences customers with contamination-control equipment, sterilization technologies, and related maintenance services. Through its mix of consumables, capital equipment, and recurring service offerings, the company plays an important role in helping healthcare and production environments maintain sterile conditions and support patient care across global markets.
What sector is STERIS plc in?
STERIS plc is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are STERIS plc's key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 8.4%, Operating margin 19.1%, Net margin 13.3%, ROE 10.9%, Debt-to-equity 0.23x. Definitions and interpretation are available on Stocklore.
Where can I analyze STERIS plc (STE) stock?
On Stocklore you can see STE's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.